NCT01260805View on ClinicalTrials.gov

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
BioequivalenceEthinylestradiolGestodeneHarmonet
Interventions
DRUG

Reference Drug

Femiane® Ethinylestradiol 0,02mg + Gestodene 0,075mg sugar coated tablets single dose

DRUG

Test Drug

Harmonet® Ethinylestradiol 0,02mg + Gestodene 0,075mg sugar coated tablets single dose

Trial Locations (1)

74935-530

Pfizer Investigational Site, Aparecida de Goiânia

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY